Obtenga las últimas noticias sobre las acciones de Nexalin Technology con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de NXL

Últimas noticias sobre

Nexalin Technology

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Section,Of,A,Financial,Newspaper,Titled,Key,Movers

News

Pre-Market Outlook

Markets

Movers

Trading Ideas

AMBO

APGE

ATON

BAOS

DGNX

GLDG

GTBP

PLUG

RELL

TCRT

TELO

TTRX

VNTG

WOLF

XBIO

Connexa Sports Technologies Inc. - Common Stock

YYAI

ZCMD

RELL sorprendió al mercado con ganancias y ventas superiores a las previstas, impulsando sus acciones más del 20 % en el premercado.

Acciones de Richardson Electronics (RELL) suben un 20%; Aquí están 20 acciones que se mueven en el premarket

Nexalin Technology Inc

NEXLIVING CMNTYS INC by NEXLIVING CMNTYS INC.

Nexalin Technology Inc Warrants (15/09/2025)

Nuix Ltd

Press Releases

Nexalin Technology Reconstitutes Scientific Advisory Board with Leading Experts to Advance Alzheimer's Program Amid Encouraging Data

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on June 3

Nexalin Technology Appoints Highly Experienced Financial Leader Justin Van Fleet as CFO to Support Nexalin's Next Phase of Growth and Strategic Initiatives

Join Nexalin Technology's Exclusive Live Investor Webinar and Q&A Session on September 9

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer's Disease with Gen-2 SYNC Neurostimulation Device

Nexalin Technology Announces Attendance at the 2025 Maxim Growth Summit

Nexalin Technology Expands Scientific Advisory Board with Appointment of Dr. Robert Rothstein to Support Alzheimer's and Traumatic Brain Injury Programs

Nexalin's DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer's and Dementia Across Three Peer-Reviewed Studies

Nexalin Technology Announces Regulatory Approval to Sell Gen 2 SYNC, 15 mA Neurostimulation DIFS™ Device in Israel

NXLIW

Adagio Medical Holdings, Inc - Common Stock

Adagio Medical Holdings

Envoy Medical, Inc. - Class A Common Stock

Envoy Medical

Co-Diagnostics

electroCore

Ekso Bionics Holdings, Inc. - Common Stock

Ekso Bionics Holdings

Femasys

SeaStar Medical Holding Corporation - Common Stock

SeaStar Medical Holding

Inspira Technologies Oxy B.H.N. Ltd. - Ordinary Shares

Inspira Technologies Oxy

Iridex

Milestone Scientific

Modular Medical

Myomo

NeuroOne Medical Technologies Corporation - Common Stock

NeuroOne Medical Tech

Neuraxis

enVVeno Medical Corporation - Common Stock

enVVeno Medical

Profusa

Predictive Oncology

Precision Optics Corporation, Inc. - Common stock

Precision Optics Corp

Vicarious Surgical Inc. Class A Common Stock

Vicarious Surgical

Strata Skin Sciences, Inc. - Common Stock

Strata Skin Sciences

Tenon Medical

Trinity Biotech plc - American Depositary Shares

Trinity Biotech

Beyond Air

JIN MEDICAL INTERNATIONAL LTD. - Ordinary Shares

Comments

Nexalin Technology Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL